Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Adam H Schechter. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Adam H Schechter reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:DVA / DaVita Inc. Director 5,692
US:LH / Labcorp Holdings Inc. President & CEO, Director 107,234
US:MRK / Merck & Co., Inc. EVP & Pres-Global Human Health 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Adam H Schechter. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Adam H Schechter conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-18 2026-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 250 5,692 4.59
2026-05-13 2026-05-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,903 107,234 -5.22 254.50 -1,502,314 27,291,053
2026-03-30 2026-03-26 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -26,106 113,137 -18.75 268.38 -7,006,328 30,363,708
2026-03-30 2026-03-26 4 LH LABCORP HOLDINGS INC.
Common Stock
A - Award 58,470 139,243 72.39
2026-03-17 2026-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 332 5,442 6.50
2026-03-05 2026-03-03 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale -8,705 80,773 -9.73 279.96 -2,437,047 22,613,169
2026-02-13 2026-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,521 89,478 -1.67 289.89 -440,923 25,938,777
2026-02-13 2026-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,656 90,999 4.19
2026-02-13 2026-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,273 87,343 -5.69 284.38 -1,499,536 24,838,602
2026-02-10 2026-02-09 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,352 92,616 -1.44 274.01 -370,462 25,377,710
2026-02-10 2026-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,249 93,968 3.58
2026-02-10 2026-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,315 90,719 -1.43 277.20 -364,518 25,147,307
2026-02-10 2026-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 4,460 92,034 5.09
2025-11-17 2025-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 411 5,110 8.75
2025-11-13 2025-11-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,745 87,574 -6.16 262.75 -1,509,499 23,010,068
2025-08-19 2025-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 369 4,699 8.52
2025-08-13 2025-08-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,643 93,319 -5.70 266.78 -1,505,440 24,895,643
2025-05-16 2025-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 348 4,330 8.74
2025-05-13 2025-05-12 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,105 98,962 -5.81 248.73 -1,518,497 24,614,818
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -13,584 105,067 -11.45 231.67 -3,147,005 24,340,872
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
A - Award 30,469 118,651 34.55
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 349 3,982 9.61
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,226 88,182 -1.37 245.14 -300,542 21,616,935
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 2,963 89,408 3.43
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,121 86,445 -6.61 244.62 -1,497,319 21,146,176
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,345 92,566 -1.43 246.27 -331,233 22,796,229
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,250 93,911 3.58
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,240 90,661 -1.35 247.74 -307,198 22,460,356
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 4,460 91,901 5.10
2024-11-19 2024-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 312 3,633 9.39
2024-11-13 2024-11-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,189 87,441 -6.61 243.47 -1,506,836 21,289,260
2024-08-19 2024-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 333 3,321 11.14
2024-05-17 2024-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 363 2,988 13.83
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -31,799 93,630 -25.35 216.57 -6,886,709 20,277,449
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 72,435 125,429 136.69
2024-03-19 2024-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 366 2,625 16.20
2024-02-13 2024-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,231 52,994 -2.27 227.45 -279,991 12,053,485
2024-02-13 2024-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,964 54,225 5.78
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,149 51,261 -2.19 223.71 -257,043 11,467,598
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,250 52,410 6.61
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -822 49,160 -1.64 221.54 -182,106 10,890,906
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,094 49,982 6.60
2023-11-17 2023-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 529 2,259 30.58
2023-08-17 2023-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 475 1,730 37.85
2023-05-17 2023-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 516 1,255 69.82
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -18,646 46,888 -28.45 224.70 -4,189,756 10,535,734
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 42,353 65,534 182.71
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 658 739 812.35
2023-02-14 2023-02-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,170 23,181 -4.80 248.13 -290,312 5,751,902
2023-02-14 2023-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,656 24,351 12.24
2023-02-07 2023-02-06 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,368 21,695 -5.93 244.50 -334,476 5,304,428
2023-02-07 2023-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 23,063 17.93
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -805 19,556 -3.95 254.99 -205,267 4,986,584
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 20,361 15.77
2022-11-16 2022-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 81 81
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -893 17,588 -4.83 222.56 -198,746 3,914,385
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 18,481 12.18
2022-09-29 3 DVA DAVITA INC.
No securities are beneficially owned
0
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 28,100 28,100
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 7,970 19,031 72.05
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,507 11,061 -24.07
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,412 16,474 -7.89 277.48 -391,802 4,571,206
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 17,886 24.39
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,773 14,568 -15.99
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -803 14,379 -5.29 273.18 -219,364 3,928,055
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 15,182 22.35
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,007 17,341 -10.37
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -886 12,409 -6.66 288.78 -255,859 3,583,471
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 13,295 17.78
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,506 19,348 -15.34
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,028 11,288 -8.35 223.78 -230,046 2,526,029
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,506 12,316 39.80
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 29,000 29,000
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 8,320 22,854 57.25
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,006 14,534 -12.13
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -885 8,810 -9.13 207.23 -183,399 1,825,696
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,006 9,695 26.09
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,227 16,540 -6.91
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,227 7,689 18.99
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 45,600 45,600
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 10,520 17,767 145.16
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 65,100 65,100
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 24,800 24,800
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 6,020 7,247 490.63
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,227 1,227
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,038 0 -100.00
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,038 6,462 19.14
2019-02-14 2018-11-19 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -610 5,424 -10.11
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -277,879 0 -100.00
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -145,135 0 -100.00 73.66 -10,691,181
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -132,744 145,135 -47.77 73.98 -9,819,764 10,736,391
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 277,879 277,879 39.29 10,917,866 10,917,866
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 0 -100.00
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -7,360 55,406 -11.73 70.18 -516,511 3,888,286
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 70.18 -7,017,780
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 100,000 -50.00
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -34,094 62,766 -35.20 61.00 -2,079,785 3,828,819
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 61.00 -6,100,160
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-05-08 2018-05-04 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 139,063 139,063
2018-03-01 2018-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 34,094 34,094 54.72 1,865,624 1,865,624
2018-02-14 2018-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,038 1,038
2018-02-09 2018-02-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
S - Sale X -1,263 6,034 -17.31 169.29 -213,813 1,021,496
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,263 0 -100.00
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,263 7,297 20.93
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,994 200,000 -20.32
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,608 62,766 -44.64 61.63 -3,118,971 3,868,267
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,994 0 -100.00 61.63 -3,142,760
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,994 50,994 36.56 1,864,341 1,864,341
2017-12-18 2017-12-15 4 MRK Merck & Co., Inc.
Common Stock
G - Gift -750 113,374 -0.66
2017-05-09 2017-05-05 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 162,625 162,625
2017-04-10 2017-02-27 4/A MRK Merck & Co., Inc.
Common Stock
A - Award 37,758 37,758 65.85 2,486,364 2,486,364
2017-04-04 2017-04-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -53,850 116,336 -31.64 63.48 -3,418,166 7,384,507
2017-03-01 2017-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 39,970 39,970 65.85 2,632,024 2,632,024
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,560 1,263 -55.26
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,560 6,034 34.87
2017-02-09 2017-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,263 2,823 80.96
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -26,135 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -10,200 250,994 -3.91
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -36,335 0 -100.00 63.73 -2,315,699
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 10,200 36,335 39.03 36.56 372,912 1,328,408
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 26,135 26,135 33.49 875,261 875,261
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -39,200 26,135 -60.00
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -39,200 0 -100.00 62.61 -2,454,308
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 39,200 39,200 33.49 1,312,808 1,312,808
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,000 0 -100.00 57.69 -2,884,415
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.30 2,215,000 2,215,000
2016-05-12 2016-05-10 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 258,065 258,065
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,237 1,560 -44.23
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,237 4,474 38.21
2016-02-24 2016-02-22 4 MRK Merck & Co., Inc.
Common Stock
A - Award 37,223 37,223 50.77 1,889,812 1,889,812
2016-02-11 2016-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,560 2,797 126.11
2015-05-11 2015-05-11 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -10,634 0 -100.00 60.44 -642,768
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Restricted Stock Unit
M - Exercise -19,343 0 -100.00 59.86 -1,157,872
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
F - Taxes -8,709 10,634 -45.02 59.86 -521,321 636,551
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,343 19,343
2015-05-05 2015-05-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 235,294 235,294
2015-03-13 2015-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,237 1,237
2015-02-25 2015-02-23 4 MRK Merck & Co., Inc.
Common Stock
A - Award 22,198 22,198 58.30 1,294,143 1,294,143
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,503 0 -100.00
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,503 3,237 86.68
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -19,200 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -74,200 0 -100.00 62.48 -4,636,224
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 74,200 7.23 34.47 172,350 2,557,674
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,200 69,200 38.40 35.09 673,728 2,428,228
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.19 2,209,500 2,209,500
2014-11-25 2014-11-24 4 MRK Merck & Co. Inc.
Phantom Stock
S - Sale -2,779 0 -100.00
2014-08-25 2014-08-25 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -22,000 70,795 -23.71 59.70 -1,313,380 4,226,396
2014-05-15 2014-05-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,503 1,503
2014-05-14 2014-05-14 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -10,527 0 -100.00 55.91 -588,584
2014-05-13 2014-05-09 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 209,078 209,078
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,593 0 -100.00
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,593 1,734 1,129.79 98.96 157,643 171,597
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -19,147 0 -100.00 58.22 -1,114,738
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -8,620 10,527 -45.02 58.22 -501,856 612,882
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 19,147 19,147
2014-02-26 2014-02-24 4 MRK Merck & Co. Inc.
Common Stock
A - Award 22,287 22,287 56.18 1,252,084 1,252,084
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -3,000 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -2,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
I - Other -4,040 0 -100.00 55.70 -225,049
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -18,000 0 -100.00 55.61 -1,000,935
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 2,500 18,000 16.13 47.39 118,475 853,020
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 3,000 15,500 24.00 45.41 136,230 703,855
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,500 12,500 48.24 603,000 603,000
2013-05-16 2013-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,593 1,593
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -12,188 0 -100.00 44.98 -548,216
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -5,488 22,416 -19.67 44.98 -246,850 1,008,252
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,188 27,904 77.55
2013-05-08 2013-05-06 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 244,767 244,767
2013-04-03 2013-04-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 141 141
2013-02-27 2013-02-25 4 MRK Merck & Co. Inc.
Common Stock
A - Award 8,136 15,568 109.47 42.52 345,943 661,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -10,670 0 -100.00 41.42 -441,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -3,238 7,432 -30.35 41.42 -134,118 307,833
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 10,670 10,670
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -61,200 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -56,300 14,900 -79.07 45.60 -2,567,257 679,434
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 71,200 7.55 28.42 142,100 2,023,504
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 66,200 8.17 31.84 159,200 2,107,808
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 61,200 61,200 23.45 1,435,140 1,435,140
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 277,879 277,879
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Restricted Stock Unit
A - Award 19,343 19,343
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -11,475 0 -100.00 38.27 -439,148
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -4,535 7,035 -39.20 38.27 -173,554 269,226
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 11,475 11,570 12,089.51
2012-03-01 2012-02-28 4 MRK Merck & Co. Inc.
Common Stock
A - Award 9,194 9,194 38.38 352,866 352,866
2010-05-06 3 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
9,804
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)